Proffitt & Goodson Inc Atai Life Sciences N.V. Transaction History
Proffitt & Goodson Inc
- $654 Million
- Q2 2025
A detailed history of Proffitt & Goodson Inc transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Proffitt & Goodson Inc holds 2,000 shares of ATAI stock, worth $7,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$7,140% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
101Shares Held
23.7MCall Options Held
351KPut Options Held
170K-
Ubs Group Ag5.54MShares$19.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.29MShares$11.8 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.59MShares$9.26 Million0.42% of portfolio
-
Davidson Kempner Capital Management LP New York, NY1.41MShares$5.05 Million0.07% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$4.67 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $592M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...